UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine
6:47 am Thursday, October 21st, 2021
(Reuters) – The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome (GBS), as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency’s website showed on Thursday.
Medicines and Healthcare products Regulatory Agency’s (MHRA) decision comes after the European medicines agency added GBS as a possible side-effect last month.
(Reporting by Yadarisa Shabong in Bengaluru; Editing by Shinjini Ganguli)
